GPTHEALTH
GPT Healthcare Limited
If management delivers what it guided
arithmetic on filed guidance and past valuations · not a price target
GPTHEALTH
FY26 → FY28 · 2 years of guidance · ~1.7 years from today₹170 today
BEAR
₹221
+30%+17% a yr
8.7% a year · 36.3x exit
BASE
₹381
+124%+62% a yr
15% a year · 55.9x exit
BULL
₹504
+196%+92% a yr
20.4% a year · 67.5x exit
Where the market has priced it
30x33x today136x
- this company has too little filed history for a multiple band of its own, so the exit multiple is the median of 11 Hospital/Nursing Management peers
- at 33x its FY26 earnings the stock trades below the bottom of its own ten-year range (36x)
How these numbers are produced
| Earnings base | FY26 fiscal year EPS ₹5.15 (screener) |
|---|---|
| Guided growth | 15% a year, said on the call of 22-May-2026 · transcript |
| Read across as | operating: revenue growth, margin held flat — medium confidence |
| Delivery calibration | 0.58x / 1x / 1.36x of what was guided — measured: 76 annual guided-vs-filed pairs + 77 near-complete quarterly years — NSE transcripts against the companies' own filings |
| Exit multiple | 36.31x / 55.92x / 67.46x, this company’s own p20 / median / p80 across 11 filed years |
| Filed-industry peers | median 55.92x across 11 peers — the cross-check, not the input |
| Arithmetic | base EPS × (1 + guided growth × delivery)2 × exit multiple |
Arithmetic on management’s own guidance and this company’s own past valuations. Not a price target, not a recommendation, and not a forecast of what the stock will do.
What management said
from NSE earnings-call filings · extracted, not interpreted
generic growth 8%revenue growth 15%
Management: We expect the ARPOB to grow by around 8% through a mix of tariff increase as well as specialty optimization.
Call 22-May-2026 · bridge confidence medium · transcript PDF